Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.
Nalagatla N, Falloon K, Tran G, Borren NZ, Avalos D, Luther J, Colizzo F, Garber J, Khalili H, Melia J, Bohm M, Ananthakrishnan AN. Nalagatla N, et al. Among authors: tran g. Clin Gastroenterol Hepatol. 2019 Feb;17(3):502-509.e1. doi: 10.1016/j.cgh.2018.06.031. Epub 2018 Jun 23. Clin Gastroenterol Hepatol. 2019. PMID: 29944926 Free PMC article.
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
Bohm M, Xu R, Zhang Y, Varma S, Fischer M, Kochhar G, Boland B, Singh S, Hirten R, Ungaro R, Shmidt E, Lasch K, Jairaith V, Hudesman D, Chang S, Lukin D, Swaminath A, Sands BE, Colombel JF, Kane S, Loftus EV Jr, Shen B, Siegel CA, Sandborn WJ, Dulai PS; VICTORY Collaboration. Bohm M, et al. Aliment Pharmacol Ther. 2020 Aug;52(4):669-681. doi: 10.1111/apt.15921. Epub 2020 Jul 13. Aliment Pharmacol Ther. 2020. PMID: 32656800 Free PMC article.
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Lukin D, Faleck D, Xu R, Zhang Y, Weiss A, Aniwan S, Kadire S, Tran G, Rahal M, Winters A, Chablaney S, Koliani-Pace JL, Meserve J, Campbell JP, Kochhar G, Bohm M, Varma S, Fischer M, Boland B, Singh S, Hirten R, Ungaro R, Lasch K, Shmidt E, Jairath V, Hudesman D, Chang S, Swaminath A, Shen B, Kane S, Loftus EV Jr, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS. Lukin D, et al. Among authors: tran g. Clin Gastroenterol Hepatol. 2022 Jan;20(1):126-135. doi: 10.1016/j.cgh.2020.10.003. Epub 2020 Oct 8. Clin Gastroenterol Hepatol. 2022. PMID: 33039584 Free PMC article.
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
Gabara C, Aibar J, Nishimoto Y, Yamashita Y, Prandoni P, Barnes GD, Bikdeli B, Jiménez D, Demelo-Rodríguez P, Peris ML, Nguyen ST, Monreal M; Registro Informatizado Enfermedad Trombo Embólica Investigators. Gabara C, et al. J Thromb Haemost. 2024 May 16:S1538-7836(24)00289-7. doi: 10.1016/j.jtha.2024.05.007. Online ahead of print. J Thromb Haemost. 2024. PMID: 38762019
The prognostic value of blood cellular indices in pulmonary embolism.
Siddiqui F, Tafur A, Hussain M, García-Ortega A, Darki A, Fareed J, Jiménez D, Bikdeli B, Galeano-Valle F, Fernández-Reyes JL, Pérez-Pinar M, Monreal M; RIETE Investigators. Siddiqui F, et al. Am J Hematol. 2024 May 30. doi: 10.1002/ajh.27379. Online ahead of print. Am J Hematol. 2024. PMID: 38816957
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C).
David P, Sinha S, Iqbal K, De Marco G, Taheri S, McLaren E, Maisuria S, Arumugakani G, Ash Z, Buckley C, Coles L, Hettiarachchi C, Payne E, Savic S, Smithson G, Slade M, Shah R, Marzo-Ortega H, Keen M, Lawson C, Mclorinan J, Nizam S, Reddy H, Sharif O, Sultan S, Tran G, Wood M, Wood S, Ghosh P, McGonagle D. David P, et al. Among authors: tran g. EBioMedicine. 2024 May 8;104:105136. doi: 10.1016/j.ebiom.2024.105136. Online ahead of print. EBioMedicine. 2024. PMID: 38723554 Free PMC article.
332 results